◆ 会议时间：2025年9月26-29日
◆ 会议地点：美国 明尼阿波利斯

◆ 会议简介：

2025年美国心力衰竭学会(HFSA ASM 2025)将于2025年9月26-29日在美国明尼阿波利斯举行。

美国心力衰竭学会(HFSA)是一个多学科组织，致力于通过合作、教育、研究、创新和倡导来改善和扩大心力衰竭护理。HFSA成员包括医生、科学家、护士、执业护士、药剂师和患者。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）。

HFSA ASM 2025 - Annual Scientific Meeting of the Heart Failure Society (HFSA)

Date:
26 - 29 September 2025

Venue:
Minneapolis Convention Center, Minneapolis, MN, USA

The HFSA Annual Scientific Meeting 2025 is where heart failure teams gather! In 2025, we’ll bring you the best of heart failure science, research and practical management and connection opportunities. ASM 2025 will be held September 26-29 in Minneapolis, MN.

摘要征文投稿：

Abstract Submission Timelines

点此提交摘要>>>Submit Abstract>>>

Abstracts on heart failure research are invited in the following categories:

• Advanced heart failure, durable mechanical circulatory support, and transplantation 
• Basic and translational science, biomarkers, -omics, precision medicine  
• Business of heart failure (health policy and economics) 
• Caregiving, patient perspectives, palliation and end of life 
• Cardiogenic shock, temporary mechanical circulatory support, and critical care cardiology
• Cardio-oncology 
• Comorbidities (kidney disease, diabetes, lung disease, sleep disorders, anemia, COVID-19) 
• Epidemiology and global heart failure 
• Genetics and inherited cardiomyopathies 
• HFpEF clinical care, management strategies, new interventions
• HFrEF/HFimpEF/HFmrEF clinical care, management strategies, new interventions
• Hospitalized HF, readmissions
• Infiltrative cardiomyopathies (sarcoidosis, amyloidosis) and myocarditis 
• Leadership and education
• Non-MCS heart failure devices (remote monitoring, EP devices, structural, other innovations)  
• Nutrition, metabolism, obesity, and exercise 
• Population health, social determinants of health and disparities of care, outcomes research  
• Pulmonary hypertension and right heart failure 
• Quality improvement and implementation
• Other (please specify)

*Note: Case Studies/Reports and Performance Improvement Initiative abstracts are not eligible for awards. Case Studies/Reports should not be submitted to the call for general abstracts but should be reserved for the special call for the Case Competition that will go out in late May. Those case reports will be submitted to the same submission portal with Late Breaking Clinical Research. More information about the Case Competition and what it entails can be found on the HFSA site here.

Writing an Abstract

• Title: Make the title dynamic and conclusive, rather than descriptive
• Structure: A well-written abstract typically has the following identified sections: Introduction, Hypothesis, Methods, Results and Conclusions.
• Category: Check submission category carefully to assure proper consideration.
• Length: Maximum length is 2800 characters, including tables and graphs.

Title

An abstract must have a short, specific title (no abbreviations) that clearly indicates the nature of the investigation. Make the title dynamic and conclusive, rather than descriptive.

Text

• Briefly describe the objectives of the study unless they are contained in the title. If applicable, include a brief statement of methods. State findings in sufficient detail to support conclusions.   Abstracts should not describe research in which the chemical identity or source of the reagent   is proprietary or cannot be revealed.
• Use generic names wherever possible. Use trade names only when necessary.
• Avoid beginning sentences with numerals.
• Standard abbreviations may be used without definition. Nonstandard abbreviations should be   placed in parentheses after the first use of the word or phrase abbreviated.
• No references, credits or grant support should be included in the abstract.
• No identifying information about patients participating in a study or trial should be used.
• Proofread abstracts carefully to avoid errors before submission. No corrections will be allowed   or made once abstract has been submitted.

Abstract Contents

The size limit for an abstract 2,800 characters, including characters in the following: abstract title, body, and table(s) and image(s). Adding a Table/Image removes 320 characters from your character limit. Abstract authors and institutions do not count towards the character limit.

ePoster

HFSA will be utilizing ePosters at ASM 2025. An ePoster is a digital presentation of a poster. There will be no hardcopy or paper posters. Attendees will be able to view ePosters in the ePoster Hub in the Exhibit Hall during the Annual Scientific Meeting, regardless of day and time of presentations. ePoster presenters will have their posters featured for a 30 minute slot, and are requested to be present by their poster during that time slot to engage in informal Q&A with any viewers.

More information on ePoster uploads and oral abstract slide uploads will be forthcoming closer to the meeting.

Guidelines

Author Names

If an author’s name appears on more than one abstract, it must be identical on each abstract. The submitting author is designated as the presenting or primary author – the presenting   author is shown in green in Oasis. The senior author must always be listed last.

Abstract Data

1. The Heart Failure Society of America is a forum for presentation of novel research findings. Therefore, work covered by the abstract must not have been published as a manuscript or abstract prior to March 17, 2025.
2. Abstract data may not be presented at a national meeting or world congress in the United States prior to July 1, 2025.
3. Data should not be “split” to create several abstracts from one. Splitting will result in reduced scores for related abstracts.
4. Abstracts containing identical or nearly identical data submitted from the same institution or individual will be disqualified.
5. Informed consent: any studies involving human subjects must conform to the principles of the Declaration of Helsinki of the World Medical Association (Clinical Research 1996;14:103) and must meet all of the requirements governing informed consent of the country in which the study was performed. Any procedures performed must meet with prevailing ethical standards.
6. Use of Animals: All studies involving the use of animals must conform with the 1991 revision of “Guiding Principles in the Care and Use of Animals” (American Physiological Association).
7. Encore Presentations from HFSA 2024: Please contact HFSA for any queries on potential re-submission of your accepted 2024 Annual Meeting abstract to the 2025 Annual meeting. Inquiries can be sent to aleong@hsa.org. Inquiries must be received by February 28 for consideration, and are not guaranteed acceptance in 2025. 

Award Competitions

If submitting for an award competition, please check the appropriate box and provide required information. Abstracts submitted for award competition cannot be submitted as ePoster Presentation Only. An Oral Presentation will be required.

Co-Author Approval

The submitting author must verify that all co-authors have read and approved the abstract submission.

Disclosure Form

A disclosure form identifying commercial relationships must be completed online by the submitting author. The submitting author must have a current disclosure status before March 17, 2025, 11:59 PM ET or the abstract will remain incomplete and will not be reviewed.

The submitting author must verify that no relevant COIs exist for co-authors listed on the abstract.

Abstract Submission Fee

The abstract submission fee is $35.00 (USD) for non-members. This non-refundable fee applies to a non-member who is the presenting author on an abstract. Email info@hfsa.org if you are unsure of your membership status or number.

Presenting authors who are members of the Society in good standing (membership dues current) do not need to pay the abstract submission fee. Note: If the presenting author is not a member, or has a membership application pending and not approved at the time of submission, the abstract submission fee will need to be paid. Payment must be submitted with your abstract submission. The Society accepts MasterCard, Visa, and American Express.

Note: Your abstract is not complete until the payment is processed. However, payment alone does not make your abstract complete. All other steps of the abstract submission must be completed as well.
 

Abstract Submissions by Industry

Abstract submissions from industry are allowed. Submissions must focus on science and research, not on specific products or services. Abstract presentations cannot be sales presentations or endorsements for products or services.

Abstract Withdrawal

Withdrawal of accepted abstracts must be received in writing (via email) by HFSA no later than July 18, 2025 to avoid publication in the Journal of Cardiac Failure electronic supplemental issue.

◆ 参会对象：医师、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。